MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

MDS Virtual Congress 2021

September 17-22, 2021. Virtual Congress. www.mdscongress.org

View by Title View Categories
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • Evaluation of bedside tests of attention in delirium superimposed on Parkinson’s disease and dementia

    R. Lawson, S. Richardson, D. Kershaw, D. Davis, B. Stephan, L. Robinson, C. Brayne, L. Barnes, D. Burn, A. Yarnall, JP. Taylor, S. Parker, L. Allan (Newcastle Upon Tyne, United Kingdom)

  • Evaluation of Care delivery model for integrated care and self-management for people with Parkinson’s disease with Deep Brain Stimulation

    D. Dash, D. Cote, J. Conway, A. Basndwah, D. Grimes, T. Mestre (Ottawa, Canada)

  • Evaluation of cognitive function in patients with Essential Tremor in Mexican population

    A. Abundes-Corona, M. Rodríguez-Violante, A. Cervantes-Arriaga, H. Estrada-Rodriguez, L. Gaibor-Noboa, D. Vazquez-Guevara (Mexico City, Mexico)

  • Evaluation of CSF Assay usability for Huntington’s Disease (HD) Clinical Studies (mHTT, tHTT and NFL in HDClarity)

    D. Langbehn, D. Macdonald, C. Sampaio, A G. Ehrhardt (Iowa City, USA)

  • Evaluation of Health-Related Quality of Life for Individuals with Huntington’s Disease and Care Partners in Canada

    N. Budd, T. Mestre, E. Shaw, M. Mayer, P. Ekwaru, S. Mcmullen, E. Graves, J. Wu, B. Maturi, T. Cowling (Mississauga, Canada)

  • Evaluation of Motor Function Using Motor Testing App and Deep Learning for the Treatment of Lewy Body Dementia

    X. Dang, Y. Guan, K. Deng, J. Wang, H. Zhang, C. Battioui, M. Pugh, B. Winger, J. Yang, K. Biglan (Cambridge, USA)

  • EVALUATION OF MOTOR SPEECH DISORDERS IN PATIENTS WITH PARKINSON’S DISEASES.

    J. Santos, M. Olchik, R. Rech, I. Klein, A. Bertodo (Porto Alegre, Brazil)

  • EVALUATION OF THE ABSENCE OF NIGROSOME 1 BY MAGNETIC RESONANCE 3 TESLA IN PARKINSON’S DISEASE ACCORDING TO TIME OF EVOLUTION TO DIAGNOSIS VS MESENCEPHALIC ECOGRAPHY.

    J. Bestoso, L. Ciancaglini, C. Stefani, F. Silveira, M. Pérez Akly, J. Norscini, J. Funes, C. Besada, D. Bauso (Buenos Aires, Argentina)

  • Evaluation of the QTc prolongation risk of deutetrabenazine

    F. Schneider, B. Darpo, M. Gutierrez, M. Gordon, L. Rabinovich-Guilatt (Ulm, Germany)

  • Event-related oscillations in patients with Dementia with Lewy Bodies with and without mutations in the GBA gene

    Y. Rosenblum, N. Bregman, A. Thaler, A. Orr-Urtreger, N. Giladi, A. Mirelman, T. Shiner (Tel Aviv, Israel)

  • « Previous Page
  • 1
  • …
  • 48
  • 49
  • 50
  • 51
  • 52
  • …
  • 132
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley